Dechra Pharmaceuticals (DPH) Now Covered by JPMorgan Chase & Co.

Share on StockTwits

JPMorgan Chase & Co. initiated coverage on shares of Dechra Pharmaceuticals (LON:DPH) in a research note published on Monday morning. The brokerage issued an overweight rating and a GBX 3,000 ($39.20) price target on the stock.

Separately, HSBC cut their target price on shares of Dechra Pharmaceuticals from GBX 2,770 ($36.19) to GBX 2,700 ($35.28) and set a buy rating on the stock in a research note on Monday, March 11th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company has a consensus rating of Buy and a consensus price target of GBX 2,711 ($35.42).

Shares of LON DPH opened at GBX 2,562 ($33.48) on Monday. The firm has a market cap of $2.63 billion and a P/E ratio of 105.87. Dechra Pharmaceuticals has a 12-month low of GBX 1,992 ($26.03) and a 12-month high of GBX 3,180 ($41.55). The company has a debt-to-equity ratio of 62.79, a quick ratio of 1.58 and a current ratio of 2.51.

The business also recently announced a dividend, which will be paid on Monday, April 8th. Investors of record on Thursday, March 7th will be paid a dividend of GBX 9.50 ($0.12) per share. This represents a yield of 0.38%. The ex-dividend date of this dividend is Thursday, March 7th. Dechra Pharmaceuticals’s dividend payout ratio is presently 1.16%.

Dechra Pharmaceuticals Company Profile

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide. It operates through European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development segments. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and locomotion and pain management products for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies.

Read More: What is the Rule of 72?

Analyst Recommendations for Dechra Pharmaceuticals (LON:DPH)

Receive News & Ratings for Dechra Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dechra Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Seneca Foods  Reaches New 12-Month Low at $24.60
Seneca Foods Reaches New 12-Month Low at $24.60
2 Zooms jumped following the IPO: Did you buy the wrong one?
2 Zooms jumped following the IPO: Did you buy the wrong one?
Bean Cash  24 Hour Volume Tops $11,391.00
Bean Cash 24 Hour Volume Tops $11,391.00
Brokerages Anticipate Masco Corp  to Announce $0.47 Earnings Per Share
Brokerages Anticipate Masco Corp to Announce $0.47 Earnings Per Share
Chronologic  Achieves Market Capitalization of $201,718.00
Chronologic Achieves Market Capitalization of $201,718.00
KEMET Co.  Expected to Announce Earnings of $0.96 Per Share
KEMET Co. Expected to Announce Earnings of $0.96 Per Share


© 2006-2019 Ticker Report